Effects of pumaprazole (BY841), a novel reversible proton pump antagonist, and of omeprazole, on intragastric acidity before and after cure of Helicobacter pylori infection

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 1, 1999, Pages 27-34

  Martinek J ^a,d   Blum, A L ^a   Stolte, M ^b   Hartmann, M ^c   Verdu E F ^a   Luhmann R ^c   Dorta, G ^a   Wiesel, P ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b INSTITUTE OF PATHOLOGY   (Germany)

^c ALTANA PHARMA AG   (Germany)

^d INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BY 841; OMEPRAZOLE; PROTON PUMP INHIBITOR; PUMAPRAZOLE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DIARRHEA; DOUBLE BLIND PROCEDURE; FEMALE; GRAM NEGATIVE INFECTION; HEADACHE; HELICOBACTER PYLORI; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH PH;

ADULT; ANTACIDS; ANTI-ULCER AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; GASTRIC ACID; GASTRIC MUCOSA; GASTRINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYDROGEN-ION CONCENTRATION; IMIDAZOLES; MALE; OMEPRAZOLE; PROTON PUMPS; PYRIDINES; STOMACH;

EID: 0032934393     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00440.x     Document Type: Article

References (28)

1. 1 Verdú EF, Armstrong D, Fraser R, et al. Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 1995; 36: 539-43.
2. 2 Verdú EF, Armstrong D, Idström J-P, et al. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut 1995; 37: 743-8.
3. 3 Labenz J, Tillenburg B, Peitz U, et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996; 110: 725-32.
4. 4 Bercik P, Verdú EF, Armstrong D, et al. H. pylori related increase in omeprazole effect is associated with ammonia production. Gastroenterology 1996; 110: A64(Abstract).
5. 5 Bercik P, Verdú EF, Armstrong D. et al. Apparent increase in acid output during omeprazole after cure of H. pylori infection. Gastroenterology 1997; 112: A70(Abstract).
6. 6 Gillen D, McColl KEL. Effects of omeprazole on gastric acid secretion are related to Helicobacter pylori related status. Z Gastroenterol 1996; 34: 841-2.
7. 7 Gillen D, Wirz A, McColl KEL. Degree of suppression of gastric acid secretion by omeprazole is related to H. pylori status. Gastroenterology 1997; 112: A126(Abstract).
8. 8 El-Omar E, Penman I, Ardill JES, Chittajallu RS, Howie C, McColl KEL. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995; 109: 681-91.
9. 9 El-Omar E, Penman I, Ardill JES, McColl KEL. A substantial proportion of NUD patients have the same abnormality of acid secretion as DU patients. Gut 1995; 36: 534-8.
10. 10 El-Omar E, Oien K, El-Nujumi A, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997; 113: 15-24.
11. 11 Treiber G, Klotz U. Acid secretion, response to omeprazole, and Helicobacter pylori status. Am J Gastroenterol 1997; 92: 555-6.
12. 12 Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J. Expression of cytokine mRNA in gastric mucosa with Helicobacter pylori infection. Scand J Gastroenterol 1995; 30: 1153-9.
13. +)-ATPase. Nature 1981; 290: 159-61.
14. + ATPase. Annu Rev Pharmacol Toxicol 1995; 35: 277-305.
15. 15 Von Buedingen C, Boer R, Sachs G, Simon WA. Reversible binding of acid pump antagonists to the gastric H, K ATPase. Gastroenterology 1996; 110: A287(Abstract).
16. 16 Wurst W, Hartmann M. Current status of acid pump antagonists (Reversible PPIs). Yale J Biol Med 1996; 69: 233-43.
17. 17 Price AB. The Sydney system: histological division. J Gastroenterol Hepatol 1991; 6: 209-22.
18. 18 Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 1996; 20: 1161-81.
19. 19 Van Herwaarden MA, Samsom M, Van Nispen CHM, Smout AJPM. H. pylori eradication reduces the effect of lansoprazole but not that of ranitidine on intragastric pH. Gastroenterology 1998; 114: A321(Abstract).
20. 20 Labenz J, Tillenburg B, Peitz U, et al. Effect of curing H. pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer. Gut 1997; 41: 33-6.
21. 21 Gillen D, Wirz A, Neithercut W, Ardill J, McColl KEL. Neutralization by ammonia cannot explain H. pylori's potentiation of omeprazole's efficacy. Gut 1998; 42: A80(Abstract).
22. 22 Logan RP, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995; 36: 12-16.
23. 23 Stolte M, Meining A, Schmitz JM, Alexandridis T, Seifert E. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastrooesophageal reflux disease. Aliment Pharmacol Ther 1998; 12: 247-53.
24. 24 Berstad AE, Hatlebakk JG, Maartmann-Moe H, Bestad A, Brandtzaeg P. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole. Gut 1997; 41: 740-7.
25. +-ATPase-antagonist BY 841 is more effective in elevating gastric pH in Helicobacter pylori positive than in Hp-negative volunteers. Gastroenterology 1998; 114: A268(Abstract).
26. 26 Carlsson R, Bate C, Dent J, et al. Does H. pylori infection influence the response to treatment with acid inhibition in patients with gastroesophageal reflux disease? Scand J Gastroenterol 1997; 32(Suppl. 224): F70 (Abstract).
27. 27 Holtmann G, Cain CR, Malfertheiner P. The impact of H. pylori on healing of reflux esophagitis during treatment with pantoprazole. Gastroenterology 1998; 114: A151(Abstract).
28. 28 Yeomans ND, Tulassay Z, Juhasz L, et al. A comparison of omeprazole with ranitidine for ulcers associated with non-steroidal antiinflammatory drugs. New Engl J Med 1998; 338: 719-26.